Switzerland manages Tamiflu access
This article was originally published in Scrip
Switzerland's federal office of public health says that the government has stockpiled 30 million capsules of Roche's Tamiflu (oseltamivir), enough to treat a quarter of the population in the event of an influenza pandemic. It says that its stocks are adequate for treating ill people and the healthcare professionals looking after them.
You may also be interested in...
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.